Skip to main content

Table 1 Patients’ demographic characteristics at T0

From: A double blind randomized active-controlled clinical trial on the intra-articular use of Md-Knee versus sodium hyaluronate in patients with knee osteoarthritis (“Joint”)

  Group A (MD-Knee) = 32 Group B (SUPARTZ®) = 32
Age (years ± SD) 69.41 ± 8.42 69.97 ± 9.5
Women, n (%) 25 (86.2 %) 20 (64.5 %)
BMI (kg/m2) 27.20 ± 3.78 27.3 ± 3.56
Kellgren and Lawrence, n (%)Grade II (%) 15 (51 %) 17 (55 %)
Kellgren and Lawrence, n (%)Grade III (%) 14 (49 %) 14 (45 %)
LKI ± SD 12.48 ± 2.63 12.6 ± 3.48
SF36 ± SD 91.41 ± 20.01 93.07 ± 17.3
Pain VAS (cm) ± SD 7.67 ± 1.41 7.42 ± 1.35
  1. Data are mean ± SD Standard Deviation unless otherwise indicated. BMI Body Mass Index, LKI Lequesne Knee Index, VAS Visual Analogue Scale